Abstract #1020

A zinc-sensitive MRI contrast agent differentiates healthy from cancerous prostate in a transgenic prostate cancer model

Veronica Clavijo Jordan ¹, Su-Tang Lo¹, Christian Preihs¹, Sara Chirayil¹, Wen-Hong Li¹, Neil M Rofsky¹, and Dean Sherry^1,2

¹UT Southwestern Medical Center, Dallas, TX, United States, ²UT Dallas, Richardson, TX, United States

The prostate has the highest levels of Zn(II) in the organism and there are marked differences in content between the healthy, malignant, and benign hyperplastic prostate. Given that accurate differential diagnosis between these conditions is difficult non-invasively, we introduce prostate Zn(II) as a MRI imaging biomarker. In this work we use a Gd-based zinc sensor that can sensitively detect glucose-stimulated intracellular release of Zn(II) in the healthy, and malignant mouse prostate using a transgenic adenocarcinoma model.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.